home / stock / clsd / clsd quote
Last: | $1.31 |
---|---|
Change Percent: | -2.24% |
Open: | $1.32 |
Close: | $1.34 |
High: | $1.34 |
Low: | $1.26 |
Volume: | 94,609 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.31 | $1.32 | $1.34 | $1.34 | $1.26 | 94,609 | 04-25-2024 |
$1.34 | $1.44 | $1.34 | $1.45 | $1.29 | 201,048 | 04-24-2024 |
$1.37 | $1.43 | $1.37 | $1.48 | $1.35 | 232,128 | 04-23-2024 |
$1.41 | $1.31 | $1.41 | $1.46 | $1.2935 | 299,484 | 04-22-2024 |
$1.31 | $1.33 | $1.31 | $1.45 | $1.25 | 228,503 | 04-19-2024 |
$1.32 | $1.28 | $1.32 | $1.39 | $1.24 | 331,169 | 04-18-2024 |
$1.26 | $1.18 | $1.26 | $1.27 | $1.1 | 329,284 | 04-17-2024 |
$1.15 | $1.26 | $1.15 | $1.27 | $1.15 | 332,218 | 04-16-2024 |
$1.29 | $1.27 | $1.29 | $1.3 | $1.21 | 184,316 | 04-15-2024 |
$1.25 | $1.29 | $1.25 | $1.3358 | $1.2401 | 372,800 | 04-12-2024 |
$1.3 | $1.23 | $1.3 | $1.34 | $1.23 | 181,811 | 04-11-2024 |
$1.24 | $1.28 | $1.24 | $1.32 | $1.23 | 183,218 | 04-10-2024 |
$1.29 | $1.28 | $1.29 | $1.35 | $1.2 | 307,027 | 04-09-2024 |
$1.29 | $1.28 | $1.29 | $1.37 | $1.22 | 305,829 | 04-08-2024 |
$1.3 | $1.3 | $1.3 | $1.3962 | $1.28 | 519,493 | 04-05-2024 |
$1.33 | $1.43 | $1.33 | $1.43 | $1.33 | 144,321 | 04-04-2024 |
$1.43 | $1.37 | $1.43 | $1.45 | $1.31 | 190,091 | 04-03-2024 |
$1.4 | $1.59 | $1.4 | $1.6288 | $1.23 | 727,756 | 04-02-2024 |
$1.58 | $1.52 | $1.58 | $1.61 | $1.5 | 232,988 | 04-01-2024 |
$1.53 | $1.66 | $1.53 | $1.73 | $1.5 | 442,691 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Clearside Biomedical Inc. Company Name:
CLSD Stock Symbol:
NASDAQ Market:
Clearside Biomedical Inc. Website:
The Dow Jones index closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern aro...
ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...
ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that Anthony S. Gibney has been appo...